DR M VAN HOYDONCK REUMATOLOGIE
0719.498.587 · rovalta.com · 27/09/2026
DR M VAN HOYDONCK REUMATOLOGIE
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODR M VAN HOYDONCK REUMATOLOGIE is a Private limited company incorporated in 2019. Its registered office is in Jette.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0719.498.587
- Incorporation
- 28/01/2019
- Legal form
- Private limited company
- Registered office
- Avenue Charles Woeste 44 box 7
1090 Jette · BruxellesSee on map - Contributed capital
- 20 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 127,8 k € | -22.4% | 164,7 k € | -0.4% | 165,3 k € | +10.9% | 149 k € | -0.9% | 150,4 k € |
| EBITDA | 126,8 k € | -22.7% | 164 k € | -0.2% | 164,3 k € | +10.7% | 148,4 k € | -0.9% | 149,7 k € |
| Operating result | 125,8 k € | -21.8% | 160,9 k € | +4.7% | 153,6 k € | +11.6% | 137,7 k € | -1.0% | 139 k € |
| Net result | 98,3 k € | -21.1% | 124,6 k € | +4.3% | 119,5 k € | +11.9% | 106,8 k € | -1.0% | 107,9 k € |
| Balance sheet | |||||||||
| Equity | 264,4 k € | +59.2% | 166,1 k € | -40.0% | 276,8 k € | -22.5% | 357,3 k € | +42.7% | 250,4 k € |
| Total assets | 312,1 k € | +40.8% | 221,7 k € | -31.2% | 322 k € | -20.0% | 402,6 k € | +34.8% | 298,6 k € |
| Cash | 297,5 k € | +38.1% | 215,5 k € | -30.6% | 310,3 k € | -17.8% | 377,4 k € | +45.7% | 259 k € |
| Debts | 47,7 k € | -14.2% | 55,6 k € | +22.9% | 45,2 k € | -0.2% | 45,3 k € | -5.9% | 48,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Marijke Van Hoydonck | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
MARIJKE VAN HOYDONCK | Administrator - manager | |
MARIJKE VAN HOYDONCK | Manager |
Other companies at this address
Avenue Charles Woeste 44 1090 Jette| Company | CBE no. |
|---|---|
| 0844.725.290 | |
IBUCOM● Active | 0810.398.871 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/04/2026 | 29/04/2025 | 30/04/2024 | 28/03/2023 | 30/04/2022 | 30/04/2021 |
| General meeting | 06/03/2026 | 07/03/2025 | 01/03/2024 | 03/03/2023 | 04/03/2022 | 05/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 06/03/2026 | 26/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 07/03/2025 | 29/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 01/03/2024 | 30/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 03/03/2023 | 28/03/2023 | Dutch | |
| Micro model | 30/09/2021 | 04/03/2022 | 30/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 05/03/2021 | 30/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 06/03/2020 | 14/07/2020 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Marijke Van Hoydonck | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
MARIJKE VAN HOYDONCK | Administrator - manager | |
MARIJKE VAN HOYDONCK | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202598,3 k €↓
- 2024Annual accounts 2024124,6 k €↑
- 2023Annual accounts 2023119,5 k €↑
- 2022Annual accounts 2022106,8 k €↓
- 2021Annual accounts 2021107,9 k €↑
- 2020Annual accounts 202065,6 k €↑
- 2019Annual accounts 201956,9 k €
- 28/01/2019IncorporationPrivate limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Charles Woeste 44 bte 7, 1090 JetteCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00088038 |
| CHARLES WOESTELAAN 42, 1090 Jette | accounts 2021 → 2022 | Accounts 2022 · 2023-00046476 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR M VAN HOYDONCK REUMATOLOGIECurrent | CBE, tracked since 27/09/2026 | CBE |
| VAN HOYDONCK MARIJKE | accounts 2021 → 2025 | Accounts 2025 · 2026-00088038 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.